Dalotuzumab

Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers.[1]

Dalotuzumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetIGF-1 receptor
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
ECHA InfoCard100.205.569
Chemical and physical data
FormulaC6528H10086N1730O2018S40
Molar mass146374.99 g·mol−1
 NY (what is this?)  (verify)

Dalotuzumab was developed by Merck & Co., Inc.

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.